You have 9 free searches left this month | for more free features.

Condition

Kidney Disease (1)

Relapsed and/or Refractory Multiple Myeloma (RRMM) (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Takeda (2)

Collaborator

Intervention

mezagitamab (2)

daratumumab and hyaluronidase-fihj (1)

tak-981 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

mezagitamab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Kidney Disease Trial in Worldwide (Mezagitamab)

Not yet recruiting

Kidney Disease

Mezagitamab

Northridge, California
+29 more

Aug 17, 2022

Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial in United States (TAK-981, Mezagitamab, Daratumumab and

Recruiting

Relapsed and/or Refractory Multiple Myeloma (RRMM)

TAK-981
+2 more

Scottsdale, Arizona
+11 more

Jan 6, 2022